BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27276058)

  • 1. Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation.
    Tian DM; Wang Y; Zhang XH; Liu KY; Huang XJ; Chang YJ
    PLoS One; 2016; 11(6):e0156777. PubMed ID: 27276058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early lymphocyte recovery predicts superior outcomes after unmanipulated haploidentical blood and marrow transplant for acute myeloid leukemia.
    Fu Q; Xu LP; Zhang XH; Wang Y; Chang YJ; Huang XJ
    Clin Transplant; 2016 Aug; 30(8):954-8. PubMed ID: 27219272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.
    Kim DH; Sohn SK; Won DI; Lee NY; Suh JS; Lee KB
    Bone Marrow Transplant; 2006 Jun; 37(12):1119-28. PubMed ID: 16699530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study.
    Zhao X; Gao F; Zhang X; Wang Y; Xu L; Liu K; Zhao X; Chang Y; Wei H; Chen H; Chen Y; Jiang Z; Huang X
    Sci China Life Sci; 2016 Nov; 59(11):1139-1148. PubMed ID: 27535422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of immune reconstitution at early stage after unmanipulated haploidentical stem cell transplantation between high- and standard- risk Philadelphia chromosome- negative acute lymphoblastic leukemia patients in CR1].
    Bian ZL; Chang YJ; Xu LP; Wang Y; Zhang XH; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):650-5. PubMed ID: 27587244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome.
    Chang YJ; Zhao XY; Xu LP; Liu DH; Liu KY; Chen YH; Wang Y; Zhang XH; Zhao XS; Han W; Chen H; Wang FR; Lv M; Huang XJ
    Leuk Lymphoma; 2013 Dec; 54(12):2671-7. PubMed ID: 23550991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
    Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
    Koehl U; Bochennek K; Zimmermann SY; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner HP; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T
    Bone Marrow Transplant; 2007 Mar; 39(5):269-78. PubMed ID: 17311085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies.
    Chang YJ; Zhao XY; Huo MR; Xu LP; Liu DH; Liu KY; Huang XJ
    Am J Hematol; 2011 Feb; 86(2):227-30. PubMed ID: 21264916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation].
    Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):745-50. PubMed ID: 24103870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Wang HT; Xu LP; Wang Y; Liu KY; Zhang XH; Liu DH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Huang XJ
    Leuk Lymphoma; 2016 Sep; 57(9):2133-9. PubMed ID: 26857549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
    Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
    Front Immunol; 2018; 9():1841. PubMed ID: 30154788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Huang XJ
    Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S21-3. PubMed ID: 26039202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation.
    Wang HT; Chang YJ; Xu LP; Liu DH; Wang Y; Liu KY; Huang XJ
    Bone Marrow Transplant; 2014 Jul; 49(7):927-33. PubMed ID: 24777191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.
    Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH
    Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting.
    Bondanza A; Ruggeri L; Noviello M; Eikema DJ; Bonini C; Chabannon C; van der Werf S; van Biezen A; de Wreede LC; Crucitti L; Vago L; Merluzzi M; Massei MS; Veelken H; Koc Y; Bader P; Gruhn B; Locatelli F; Ciceri F; Toubert A; Velardi A;
    Bone Marrow Transplant; 2019 Jun; 54(6):867-876. PubMed ID: 30531916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.